Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

WuXi NextCODE raises $200mm in Series C financing

Executive Summary

WuXi NextCODE Genomics (genomic data platform) raised $200mm in its Series C financing round. The round included participation from a consortium led by the Ireland Strategic Fund ($70mm), along with existing investors Temasek, Yunfeng Capital and Sequoia Capital. WuXi plans to use the proceeds to expand operations at Genomics Medicine Ireland (GMI), which the company recently acquired, and to speed up enrollment and sequencing of the entire genome of 400k people across Ireland for use in precision medicine. To date, WuXi has raised over $450mm in venture funding including a $240mm Series B round last year.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Research, Analytical Equipment & Supplies
  • Services
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies